Literature DB >> 3008063

Epidural steroid injections for low back pain and lumbosacral radiculopathy.

Honorio T Benzon1.   

Abstract

Non-surgical treatments of back pain may have prolonged and lasting benefit. Epidural steroid injections is one of the non-operative managements of back pain. These injections are recommended in patients with signs and symptoms of nerve root irritation. Relief of pain is attributed to the anti-inflammatory effect of the steroid. Patients with acute radiculopathy have better response compared to patients with chronic symptoms. Improvement may not be noted until 6 days after the injection. The depression of the hypothalamic-pituitary-adrenal (HPA) axis lasts 3 weeks. While complications have been reported, these are rare. Intrathecal steroid injection is not advisable since polyethylene glycol, the vehicle used in depot steroid preparations, may cause arachnoiditis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008063     DOI: 10.1016/0304-3959(86)90115-6

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  24 in total

Review 1.  The need for caution in interpreting high quality systematic reviews.

Authors:  K Hopayian
Journal:  BMJ       Date:  2001-09-22

2.  Selective Spinal Injections for Lower Back Pain.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

3.  Influence of neuroticism, catastrophizing, pain duration, and receipt of compensation on short-term response to nerve block treatment for chronic back pain.

Authors:  G Groth-Marnat; A Fletcher
Journal:  J Behav Med       Date:  2000-08

Review 4.  Common pain syndromes and their management.

Authors:  J E Charlton
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

5.  Metabolic and endocrinal effects of epidural glucocorticoid injections.

Authors:  Anuntapon Chutatape; Mahesh Menon; Stephanie Man Chung Fook-Chong; Jane Mary George
Journal:  Singapore Med J       Date:  2018-11-07       Impact factor: 1.858

Review 6.  A rationale for the treatment algorithm of failed back surgery syndrome.

Authors:  S R Anderson
Journal:  Curr Rev Pain       Date:  2000

Review 7.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

8.  Injectable corticosteroid preparations: an embolic risk assessment by static and dynamic microscopic analysis.

Authors:  P J MacMahon; M J Shelly; D Scholz; S J Eustace; E C Kavanagh
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-22       Impact factor: 3.825

9.  Paravertebral spinal injection for the treatment of patients with degenerative facet osteoarthropathy: Evidence of motor performance improvements based on objective assessments.

Authors:  Nima Toosizadeh; Homayoon Harati; Tzu-Chuan Yen; Cindy Fastje; Jane Mohler; Bijan Najafi; Michael Dohm
Journal:  Clin Biomech (Bristol, Avon)       Date:  2016-10-11       Impact factor: 2.063

10.  Comparison of fluoroscopically guided and blind corticosteroid injections for greater trochanteric pain syndrome: multicentre randomised controlled trial.

Authors:  Steven P Cohen; Scott A Strassels; Leslie Foster; John Marvel; Kayode Williams; Matthew Crooks; Andrew Gross; Connie Kurihara; Cuong Nguyen; Necia Williams
Journal:  BMJ       Date:  2009-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.